Temporal parameters of one-trial tolerance to benzodiazepines in four-plate test-retest

Behavioural Brain Research

Volumn 183, Issue 2, 2007, Pages 222-225

  Petit Demouliere, Benoit ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

FPT; Neophobia; OTT

Indexed keywords

BENZODIAZEPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG TOLERANCE; ELECTRIC CONDUCTIVITY; FOOTSHOCK; HABITUATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TEMPORAL CORTEX; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DRUG TOLERANCE; ELECTROSHOCK; MALE; MICE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 34548314597     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.06.005     Document Type: Article

References (14)

1. Ripoll N., Hascoët M., and Bourin M. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Res 166 (2006) 131-139
2. Masse F., Nic Dhonnchadha B.A., Hascoët M., and Bourin M. Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Behav Brain Res 177 (2007) 214-226
3. Hascoët M., Bourin M., and Couetoux du Tertre A. Influence of prior experience on mice behavior using the four-plate test. Pharmacol Biochem Behav 58 (1997) 1131-1138
4. Petit-Demoulière B, Hascoët M, Bourin M. Factors triggering abolishment of benzodiazepines effects in the four-plate test-retest. Eur Neuropsychopharmacol 2007 May 31; [Epub ahead of print].
5. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100 (1990) 281-282
6. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
7. Ripoll N., Nic Dhonnchadha B.A., Sebille V., Bourin M., and Hascoët M. The four-plates test-retest paradigm to discriminate anxiolytic effects. Psychopharmacology (Berl) 180 (2005) 73-83
8. Dal-Col M.L., Pereira L.O., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol Biochem Behav 74 (2003) 395-400
9. File S.E., Zangrossi Jr. H., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology (Berl) 111 (1993) 491-494
10. Aron C., Simon P., Larousse C., and Boissier J.R. Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology 10 (1971) 459-469
11. Calzavara M.B., Patti C.L., Lopez G.B., Abilio V.C., Silva R.H., and Frussa-Filho R. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice. Life Sci 76 (2005) 2235-2246
12. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23 (1999) 971-980
13. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology (Berl) 113 (1993) 237-242
14. Pereira J.K., Vieira R.J., Konishi C.T., Ribeiro R.A., and Frussa-Filho R. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65 (1999) PL101-PL107